scRNA-seq characterizing the heterogeneity of fibroblasts in breast cancer reveals a novel subtype SFRP4+ CAF that inhibits migration and predicts prognosis
Lvwen Ning(Chinese Academy of Sciences), Ni Xie(Xi'an University of Science and Technology), Chuntao Quan(Huazhong University of Science and Technology), Zhijie Wu(National Heart Lung and Blood Institute), Yue Wang(Virginia Tech), Peixiu Yuan(South China Agricultural University)
Cited by 17
Related Papers
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
|Nature Medicine|2009|666
Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb–MyoD pathways in muscle regeneration
|Brain|2006|329
Activating Macrophage‐Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles
|Advanced Materials|2020|278
Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses
|JNCI Journal of the National Cancer Institute|2012|252
SIRT7 antagonizes TGF-β signaling and inhibits breast cancer metastasis
|Nature Communications|2017|229